Under the new law, the Attorney General is provided with a 60-day timeline to either approve or deny applications from scientists wishing to conduct human trials with cannabis.
Medical marijuana legalization was “associated with a five percent to 20 percent relative reduction in the rate of opioid dispensing to adults younger than 65 years receiving cancer treatment.”
Autistic patients exhibited significant improvements in communication and socialization skills, among other improvements.
“[M]easures related to cannabis dispensaries … were generally consistently associated with lower drug overdose mortality outcomes across multiple studies,” investigators concluded.
The study is the largest double-blind, randomized, placebo-controlled clinical trial ever conducted involving FSX patients.